Accelerating Discovery.
Shaping the Future.
Shaping the Future.
By 2030, patents will expire for nearly 200 drugs,
and almost every major pharma company will be impacted.
and almost every major pharma company will be impacted.
Our Technology
Creating value in AI-Driven Drug Discovery by reducing costs and time-to-market.
find out more
From Fiction to Facts
From more than 50,000 AI generated molecules to optimized lead compounds against molecular targets owned by TheraGen AI and ready for preclinical stage.
New scaffolds of interest to emerge as the basis for new therapeutics.
Fast adaptation to new emerging resistances and mutations with AI.
Increase the pace of drug discovery.
